Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study) | Respiratory Research | Full Text
Overall survival (OS) according to PD-L1 expression. OS was defined as... | Download Scientific Diagram
Quantification of measurable residual disease in patients with multiple myeloma based on the IMWG response criteria | Scientific Reports
Exploring the relationship between Overall Survival (OS), Progression Free Survival (PFS) and Objective Response Rate (ORR) in patients with advanced melanoma - ScienceDirect
Survival in IPF patients. Overall survival was defined as the time from... | Download Scientific Diagram
Measures of Cancer Survival
Safety and Efficacy of Gemcitabine, Docetaxel, Capecitabine, Cisplatin as Second-line Therapy for Advanced Pancreatic Cancer After FOLFIRINOX | Anticancer Research
Full article: The Impasse on Overall Survival in Oncology Reimbursement Decision-Making: How Can We Resolve This?
Frontiers | Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 (“Oligometastatic”) and M2 (“Polymetastatic”) subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)
Evaluation of the impact of thyroiditis development in patients receiving immunotherapy with programmed cell death-1 inhibitors - Matthew Lei, Angela Michael, Seema Patel, Ding Wang, 2019
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects | Nature Communications
Cancers | Free Full-Text | Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience
1413 The overall survival (OS) and progression-free survival (PFS) of hyperprogressive disease (HDP) in lung cancer patients | Journal for ImmunoTherapy of Cancer
Survival analysis in hematologic malignancies: recommendations for clinicians | Haematologica
The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer | SpringerLink
Extrapolation from Progression Free Survival to Overall Survival in Oncology | PPT
27 Survival analysis | The Epidemiologist R Handbook
Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast. - ppt download
Overall survival (OS) according to PD-L1 expression. OS was defined as... | Download Scientific Diagram
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper
The Arts, Sciences and Medicine: Progression Free Survival (PFS)
Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases | Breast Cancer Research | Full Text
Estimating progression-free survival in patients with glioblastoma using routinely collected data | Journal of Neuro-Oncology
![PDF] Incorporating Clinical Trial Data Into Daily Cancer Care | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/30f4b9adffa198bf79a177643e74ec64b4107203/3-Table1-1.png "PDF] Incorporating Clinical Trial Data Into Daily Cancer Care | Semantic Scholar")
PDF] Incorporating Clinical Trial Data Into Daily Cancer Care | Semantic Scholar
